Elevance Health, Inc. (ELV)
NYSE
Closed
Aug 21, 2026
Day's Range
396.9652 wk Range
274.84Overview - ELV - Elevance Health, Inc.
Key Statistics
Valuation
Enterprise Value
80.53B
P/E (Trailing)
‪17.73‬
P/E (Forward)
‪13.52‬
PEG Ratio
‪-1.36‬
Price / Sales (TTM)
‪0.43‬
Price / Book
‪1.93‬
EV / EBITDA
‪9.67‬
Profitability
Profit Margin
‪2.46%‬
Operating Margin
‪4.55%‬
Return on Assets
‪3.83%‬
Return on Equity
‪11.13%‬
Ownership
Shares Outstanding
216.84M
Float
216.36M
Short % of Shares Outstanding
‪2.88%‬
Held by Insiders
‪0.19%‬
Held by Institutions
‪94.06%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪394.74‬
200-Day Avg
‪355.16‬
Dividends
Payout Ratio
‪30.34%‬
Frequency
Quarterly
Analyst Consensus
22 analysts
Average price target
‪$ 449.10‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ELV - Elevance Health, Inc.
Peers - ELV - Elevance Health, Inc.
Peer Comparison
Compared with companies in Healthcare Plans listed on NYSE.
Profile Summary - ELV - Elevance Health, Inc.
About
Elevance Health, Inc. is a diversified health company headquartered in Indianapolis, Indiana. The company focuses on supporting health at every life stage by integrating medical, pharmacy, behavioral, and complex-care services. Elevance Health operates through several key segments. Its Health Benefits segment provides…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
